6-161048646-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_005922.4(MAP3K4):​c.374A>G​(p.His125Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,286 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

MAP3K4
NM_005922.4 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.87

Publications

0 publications found
Variant links:
Genes affected
MAP3K4 (HGNC:6856): (mitogen-activated protein kinase kinase kinase 4) The central core of each mitogen-activated protein kinase (MAPK) pathway is a conserved cascade of 3 protein kinases: an activated MAPK kinase kinase (MAPKKK) phosphorylates and activates a specific MAPK kinase (MAPKK), which then activates a specific MAPK. While the ERK MAPKs are activated by mitogenic stimulation, the CSBP2 and JNK MAPKs are activated by environmental stresses such as osmotic shock, UV irradiation, wound stress, and inflammatory factors. This gene encodes a MAPKKK, the MEKK4 protein, also called MTK1. This protein contains a protein kinase catalytic domain at the C terminus. The N-terminal nonkinase domain may contain a regulatory domain. Expression of MEKK4 in mammalian cells activated the CSBP2 and JNK MAPK pathways, but not the ERK pathway. In vitro kinase studies indicated that recombinant MEKK4 can specifically phosphorylate and activate PRKMK6 and SERK1, MAPKKs that activate CSBP2 and JNK, respectively but cannot phosphorylate PRKMK1, an MAPKK that activates ERKs. MEKK4 is a major mediator of environmental stresses that activate the CSBP2 MAPK pathway, and a minor mediator of the JNK pathway. Several alternatively spliced transcripts encoding distinct isoforms have been described. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13217002).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005922.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K4
NM_005922.4
MANE Select
c.374A>Gp.His125Arg
missense
Exon 3 of 27NP_005913.3Q9Y6R4-1
MAP3K4
NM_001301072.2
c.374A>Gp.His125Arg
missense
Exon 3 of 27NP_001288001.2F5H538
MAP3K4
NM_006724.4
c.374A>Gp.His125Arg
missense
Exon 3 of 26NP_006715.3Q9Y6R4-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K4
ENST00000392142.9
TSL:1 MANE Select
c.374A>Gp.His125Arg
missense
Exon 3 of 27ENSP00000375986.4Q9Y6R4-1
MAP3K4
ENST00000366919.6
TSL:1
c.374A>Gp.His125Arg
missense
Exon 3 of 26ENSP00000355886.2Q9Y6R4-2
MAP3K4
ENST00000490904.6
TSL:1
n.374A>G
non_coding_transcript_exon
Exon 3 of 28ENSP00000446303.1F5H1X6

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.86e-7
AC:
1
AN:
1458286
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
725378
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33174
American (AMR)
AF:
0.00
AC:
0
AN:
44092
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25918
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85424
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53236
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110830
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.057
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
18
DANN
Benign
0.65
DEOGEN2
Benign
0.062
T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.35
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L
PhyloP100
2.9
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.11
Sift
Benign
0.29
T
Sift4G
Benign
0.79
T
Polyphen
0.50
P
Vest4
0.24
MutPred
0.11
Gain of MoRF binding (P = 0.0149)
MVP
0.68
MPC
0.35
ClinPred
0.46
T
GERP RS
4.8
Varity_R
0.16
gMVP
0.37
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1030379644; hg19: chr6-161469678; API